Drug Shortage Report for MYLAN-METFORMIN
Report ID | 5016 |
Drug Identification Number | 02148765 |
Brand name | MYLAN-METFORMIN |
Common or Proper name | METFORMIN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A10BA |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-03-16 |
Estimated end date | Unknown |
Actual end date | 2017-09-21 |
Shortage status | Resolved |
Updated date | 2017-09-22 |
Company comments | Resolved as 100BT reported under ID 3935 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-09-22 | French | Compare |
v6 | 2017-09-22 | English | Compare |
v5 | 2017-05-04 | French | Compare |
v4 | 2017-05-04 | English | Compare |
v3 | 2017-03-31 | French | Compare |
v2 | 2017-03-31 | English | Compare |
v1 | 2017-03-31 | English | Compare |
Showing 1 to 7 of 7